Trials / Conditions / Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

11 registered clinical trials studyying Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) — 8 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related NCT07527910	Regeneron Pharmaceuticals	Phase 2
Not Yet Recruiting	SAMe for Prevention of Liver Cancer in MASLD-Related Cirrhosis NCT07495995	Cedars-Sinai Medical Center	Phase 2
Not Yet Recruiting	The Effect of the DASH Diet on Clinical and Metabolic Parameters in Children With MASLD NCT07480811	Antalya Training and Research Hospital	N/A
Recruiting	Stimulating Fat Tissue Storage With Niacin to Reduce Fat Accumulation in the Liver. NCT06843148	Université de Sherbrooke	N/A
Recruiting	Evaluation of Miricorilant on Liver Fat in Patients With MASLD NCT06947304	Corcept Therapeutics	Phase 1
Not Yet Recruiting	A Study to Predict Recompensation in Patients With Decompensated Cirrhosis Using Spleen Stiffness and Simple B NCT07087041	Beijing Friendship Hospital	—
Recruiting	Fibrosis Lessens After Metabolic Surgery NCT06374875	Ali Aminian	Phase 4
Completed	Study on Risk Factors and Prognosis of MASLD NCT07433205	First Affiliated Hospital of Chongqing Medical University	—
Recruiting	A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic NCT05648214	Regeneron Pharmaceuticals	Phase 1 / Phase 2
Active Not Recruiting	A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Metabolic Dysfunction-Associated NCT05395481	Eli Lilly and Company	Phase 1
Completed	New Non-invasive Biomarkers of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) NCT06647095	General University Hospital, Prague	—